Higher midlife vitamin D levels linked to lower brain tau protein

A new study has found that adults with higher vitamin D levels in their 30s and 40s tend to have lower levels of tau protein in their brains about 16 years later. Tau is a key biomarker associated with dementia. The research, published this week, highlights a potential modifiable risk factor for brain health.

Researchers followed 793 adults who were around 39 years old on average and free of dementia at the study's start. They measured participants' blood vitamin D levels initially and conducted brain scans roughly 16 years later to assess tau and amyloid beta proteins, both linked to Alzheimer's disease. Levels above 30 nanograms per milliliter were deemed high, while those below were low; 34% of participants had low levels, and just 5% reported taking vitamin D supplements. After adjusting for age, sex, and depression symptoms, higher vitamin D was associated with lower tau levels, but not with amyloid beta.

ተያያዥ ጽሁፎች

Split-scene illustration of UCSF mouse study: older mouse struggles in maze with poor hippocampal neural links due to FTL1; treated mouse excels with enhanced connections.
በ AI የተሰራ ምስል

UCSF study links iron-associated protein FTL1 to age-related memory decline in mice

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

Researchers at the University of California, San Francisco report that higher levels of the iron-associated protein FTL1 in the hippocampus of older mice are tied to weaker neural connections and worse performance on cognitive tests. In the experiments, reducing FTL1 in older mice was associated with increased neuronal connectivity and improved memory performance, findings published in Nature Aging.

People who reported more mentally stimulating experiences from childhood through older age were less likely to develop Alzheimer’s disease and tended to develop symptoms years later than peers with the lowest enrichment, according to an observational study published in Neurology.

በAI የተዘገበ

Scientists at Washington University School of Medicine in St. Louis have developed a blood test that estimates when Alzheimer's symptoms may begin, using levels of the protein p-tau217. The model predicts onset within about three to four years, potentially aiding clinical trials and early interventions. This advance relies on data from 603 older adults in ongoing studies.

A large study of nearly 28 million older Americans has found that long-term exposure to fine particle air pollution increases the risk of developing Alzheimer's disease, primarily through direct effects on the brain. The research, led by Yanling Deng at Emory University, indicates that individuals with a history of stroke may face heightened vulnerability. Published in PLOS Medicine, the findings highlight the importance of cleaner air for protecting cognitive health in aging populations.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ